SeeQ Diagnostics' technology is based on know-how developed in Professor Mads Albertsen's group at Aalborg University in Denmark during rapid viral variant tracking for SARS-CoV-2. This was converted into a concept, "SepSeeQ", generally applicable for any pathogen and applied in a prospective observational clinical study (n=40) at Aalborg University Hospital emergency ward. Here SepSeeQ had 100% sensitivity compared to gold-standard blood culture with MALDI-TOF pathogen identification (n=11), and further identified a relevant pathogen in an additional 11 patients (https://journals.asm.org/doi/10.1128/spectrum.03295-24)

SeeQ diagnostics

Org chart

Teams

Offices